SCHEMBL30176384

SCHEMBL30176384

N#Cc1c(C2CCOCC2)n(-c2ccc(F)cc2)c2ccc(O)cc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.36
AOC3 Q16853 2/20 0.34
KDM4E B2RXH2 3/20 0.34
TDP2 O95551 1/20 0.32
TP53 P04637 1/20 0.32
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
ALDH1A1 P00352 2/20 0.31
GAA P10253 1/20 0.31
GFER P55789 1/20 0.31
LMNA P02545 1/20 0.31
AOC2 O75106 1/20 0.31
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
POLB P06746 1/20 0.31
PDE1A P54750 1/20 0.31
PDE1B Q01064 1/20 0.31
PDE1C Q14123 1/20 0.31
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887039 1.00 SCN9A (0.36) SCN9AAOC3KDM4ETDP2TP53
SCHEMBL23898531 0.92 KDM4E (0.37) KDM4ETDP2TP53ALDH1A1GAA
SCHEMBL23898361 0.90 KDM4E (0.36) KDM4ETDP2TP53ALDH1A1GAA
SCHEMBL23898529 0.89 GAA (0.42) KDM4ECNR1CNR2ALDH1A1GAA
SCHEMBL23898532 0.87 KCNH2 (0.40) KDM4ETDP2GAA
SCHEMBL23898537 0.84 KDM4E (0.35) KDM4ETDP2TP53ALDH1A1GAA
SCHEMBL23898538 0.83 ALDH1A1 (0.34) KDM4ETDP2ALDH1A1GAAPOLB
SCHEMBL23886826 0.81 AS3MT (0.47) SCN9ACNR1CNR2ALDH1A1TSHR
SCHEMBL30176308 0.81 AS3MT (0.47) SCN9ACNR1CNR2ALDH1A1TSHR
SCHEMBL23898541 0.78 GAA (0.44) KDM4EALDH1A1GAAGFERLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916749-A Substituted 5-hydroxyindole compounds as alpha-1 antitrypsin modulators 弗特克斯药品有限公司 2023-04-04 CN disclosed
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed